scholarly journals Radiation Safety Guide: General Definitions and Radiation Protection Rules in Nuclear Medicine Applications

2020 ◽  
Vol 6 (2) ◽  
pp. 71-89
Author(s):  
Yasemin Parlak ◽  
Bağnu Uysal ◽  
F. Suna Kıraç ◽  
Bilal Kovan ◽  
Mustafa Demir ◽  
...  
Keyword(s):  
Nuclear Medicine ◽  
Radiation Protection ◽  
Radiation Safety

scholarly journals Radiation Safety of Current European Practices of Therapeutic Nuclear Medicine: Survey Results from 20 HERCA Countries

2020 ◽  
Author(s):  
Ritva Bly
Keyword(s):  
Nuclear Medicine ◽  
Waste Management ◽  
Treatment Planning ◽  
Radiation Protection ◽  
Radiation Safety ◽  
Individual Treatment ◽  
Radiological Protection ◽  
Member States ◽  
Almost All ◽  
Therapeutic Nuclear Medicine

Abstract Purpose: New radiotherapies in nuclear medicine have been introduced in Europe during recent years. Moreover, radiation safety of therapeutic nuclear medicine should be in line with the latest European Council Directive on Basic Safety Standards (BSSD) (2013/59/Euratom). The purpose of this study was to acquire up-to-date information on nuclear medicine treatments in Europe and on the implementation of the requirements of the BSSD in HERCA (Heads of the European Radiological protection Competent Authorities) member states. Methods: An electronic questionnaire was distributed to competent authorities of 32 HERCA member states. The questionnaire addressed 33 explicitly considered treatments including 13 different radionuclides, and for each treatment, a similar set of questions was included. Questions covered the use of treatments, hospitalization of patients and waste management related to therapeutic nuclear medicine involving other radionuclides than 131 I, justification of treatments, individual treatment planning, involvement of a medical physics expert (MPE) and radiation protection instructions related to release of the patient.Results: Responses were obtained from 20 HERCA countries. All countries used 131 I-NaI for benign thyroid diseases and thyroid ablation of adults. 223 RaCl2 (Xofigo®) for bone metastases, 177 Lusomatostatin analogues for neuroendocrine tumors and 177 Lu-PSMA for castration resistant prostate cancer (PC) and PC-metastases were used in 90%, 65% and 55% of countries respectively. Only a few countries had treatment specific criteria for hospitalization and waste management for new treatments. Requirements for justification of new therapies were in place in almost all countries. Individual treatment planning was required for all therapies in 55% and for some therapies in 28% of the responding countries. Implementation of the requirement for MPEs to be closely involved in nuclear medicine practices varied to a great extend among countries. Almost all countries answered that some radiation protection instructions existed for patients released after other than 131 I treatment, however in a very few countries had specific guidelines been developed.Conclusions: There is a wide variation in therapeutic use of nuclear medicine across Europe, but there is an increasing tendency towards these types of treatments. Furthermore, the implementation of the BSSD on the involvement of MPEs and individual treatment planning including dosimetry differs from country to country. Requirements on justification are in place.

scholarly journals Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials

2019 ◽  
Vol 33 (11) ◽  
pp. 787-805 ◽  
Author(s):  
Makoto Hosono ◽  
Hideharu Ikebuchi ◽  
Seigo Kinuya ◽  
Sachiko Yanagida ◽  
Yoshihide Nakamura ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Nuclear Medicine ◽  
Radiation Protection ◽  
Radionuclide Therapy ◽  
Japanese Society ◽  
Radiation Safety ◽  
Japanese Version ◽  
Ministry Of Health ◽  
Safety Issues ◽  
Yttrium 90

Abstract We present the guideline for use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials on the basis of radiation safety issues in Japan. This guideline was prepared by a study supported by the Ministry of Health, Labour, and Welfare, and approved by the Japanese Society of Nuclear Medicine. Treatment using yttrium-90-labeled anti-P-cadherin antibody injection in Japan should be carried out according to this guideline. Although this guideline is applied in Japan, the issues for radiation protection shown here are considered internationally useful as well. Only the original Japanese version is the formal document.

Radiation exposure of the staff at the therapeutic and diagnostic nuclear medicine department

2008 ◽  
Vol 47 (04) ◽  
pp. 175-177 ◽  
Author(s):  
J. Dolezal
Keyword(s):  
Nuclear Medicine ◽  
Radiation Exposure ◽  
Effective Dose ◽  
Radiation Protection ◽  
Annual Effective Dose ◽  
Protection Measures ◽  
Professional Groups ◽  
Personal Dosimetry ◽  
The Mean ◽  
Administered Activity

SummaryAim: To assess a radiation exposure and the quality of radiation protection concerning a nuclear medicine staff at our department as a six-year retrospective study. Therapeutic radionuclides such as 131I, 153Sm, 186Re, 32P, 90Y and diagnostic ones as a 99mTc, 201Tl, 67Ga, 111In were used. Material, method: The effective dose was evaluated in the period of 2001–2006 for nuclear medicine physicians (n = 5), technologists (n = 9) and radiopharmacists (n = 2). A personnel film dosimeter and thermoluminescent ring dosimeter for measuring (1-month periods) the personal dose equivalent Hp(10) and Hp(0,07) were used by nuclear medicine workers. The wearing of dosimeters was obligatory within the framework of a nationwide service for personal dosimetry. The total administered activity of all radionuclides during these six years at our department was 17,779 GBq (99mTc 14 708 GBq, 131I 2490 GBq, others 581 GBq). The administered activity of 99mTc was similar, but the administered activity of 131I in 2006 increased by 200%, as compared with the year 2001. Results: The mean and one standard deviation (SD) of the personal annual effective dose (mSv) for nuclear medicine physicians was 1.9 ± 0.6, 1.8 ± 0.8, 1.2 ± 0.8, 1.4 ± 0.8, 1.3 ± 0.6, 0.8 ± 0.4 and for nuclear medicine technologists was 1.9 ± 0.8, 1.7 ± 1.4, 1.0 ± 1.0, 1.1 ± 1.2, 0.9 ± 0.4 and 0.7 ± 0.2 in 2001, 2002, 2003, 2004, 2005 and 2006, respectively. The mean (n = 2, estimate of SD makes little sense) of the personal annual effective dose (mSv) for radiopharmacists was 3.2, 1.8, 0.6, 1.3, 0.6 and 0.3. Although the administered activity of 131I increased, the mean personal effective dose per year decreased during the six years. Conclusion: In all three professional groups of nuclear medicine workers a decreasing radiation exposure was found, although the administered activity of 131I increased during this six-year period. Our observations suggest successful radiation protection measures at our department.

Pelatihan Keselamatan dan Keamanan Radiasi Pengion di RSUP Dr Kariadi Pada Masa Pandemi

2021 ◽  
Author(s):  
Sanggam Ramantisan ◽  
◽  
Siti Akbari Pandaningrum ◽  
Suwardi Suwardi ◽  
Syarifudin Syarifudin ◽  
...  
Keyword(s):  
Ionizing Radiation ◽  
Radiation Protection ◽  
Radiation Safety ◽  
Community Members ◽  
Medical Field ◽  
Online Delivery ◽  
Face To Face ◽  
Security Training ◽  
Field Practice ◽  
Radiation Workers

Ionizing radiation safety in the medical field, referred to as radiation safety, is an action taken to protect patients, workers, community members, and the environment from the dangers of radiation. One of the efforts to achieve this is by increasing the qualifications of radiation workers in understanding and implementing radiation protection and safety through ionizing radiation safety and security training initiated by the Radiation Protection Officer (PPR) team at Dr. RSUP. Kariadi Semarang. During the current pandemic, implemented the training by modifying what was previously done using face-to-face and field practice into online delivery of material and making videos as a substitute for field practice. As a result, these activities can run well and smoothly. The impression from the training participants stated that this training was beneficial and should be done regularly. Keywords: training, ionizing radiation, radiation protection officer

scholarly journals Radiation protection tasks on the Kiev research reactor WWR-M

2009 ◽  
Vol 24 (2) ◽  
pp. 145-151 ◽  
Author(s):  
Yuri Lobach ◽  
Valery Shevel
Keyword(s):  
Radiation Protection ◽  
Research Reactor ◽  
Radiation Safety ◽  
Radiation Monitoring ◽  
Statistical Information ◽  
Protection System ◽  
Radioactive Aerosol ◽  
Operational Experience ◽  
External Radiation ◽  
Radiation Hazards

Both the description of and the operational experience with the radiation protection system at the research reactor WWR-M are presented. The list of the factors regarding the radiation hazards during the reactor routine operation is given and the main activities on the radiation safety provision are established. The statistical information for the staff exposure, the radioactive aerosol releases and the external radiation monitoring is shown. The preliminary considerations on the system upgrading for the decommissioning are presented.

scholarly journals RADIATION HYGIENIC ASPECTS OF THE SAFETY CONTROL OF THE PERSONNEL

2019 ◽  
Vol 96 (9) ◽  
pp. 878-882
Author(s):  
Anatoly V. Simakov ◽  
Yu. V. Abramov ◽  
N. L. Proskuryakova
Keyword(s):  
Radiation Protection ◽  
Occupational Safety ◽  
Radiation Safety ◽  
Education And Training ◽  
Safety Control ◽  
Managerial Decisions ◽  
The One ◽  
Analytical System ◽  
And Training ◽  
Selection Of

Control of the radiation safety of workers is the one of the principal tasks of regulatory bodies responsible for the radiation safety and protection. This task is solved through the implementation of a set of organizational and technical measures, including:1) Organization and the execution of radiation monitoring; 2) Prediction of exposure doses to workers; 3) Selection of workers for the execution of radiation hazardous operations including emergency remedial works; 4) Planning of activities to implement the principle of the optimization of radiation protection; 6) Development and establishment of reference levels of exposure to radiation factors; 5) Organization of education and training of the personnel; 7) Continuous improvement of the occupational safety culture etc. The paper describes main actions of the management of radiation facilities aimed at the implementation of the above mentioned measures. Special attention is paid to the selection of the personnel of the required qualifications, possessing a sufficient reserve of an individual dose, to carry out radiation hazardous operations, to predict radiation doses to justify the development of the necessary protective measures and to plan actions to implement the principle of optimization of the radiation protection. The active use of the computer information and analytical system for the management of the protection from the occupational radiation is recommended. This system should include: 1. Database of individual occupational doses; 2. Database of radiation parameters characterizing the situation in workshops and at the industrial site of the radiation facility; 3. Software package for education and training of the personnel. The making of managerial decisions for the radiation protection of the personnel is aimed at increasing in the occupational reliability and, ultimately, improving the safety of radiation facilities, maintaining health and increasing the professional longevity of workers.

Sign in / Sign up

Export Citation Format

Share Document